Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 22, 2020 Filed Oct 26, 2020 14:46 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
SaleCommon Stock | 71,391 | $141.42 | $10,096,258.00 |
DisclosureSEC source: 0001127602-20-027475 · form4.xml · nonDerivative · entry 2 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,164.839 F1 · price: Weighted average price of the shares sold. The price range was $141.26 to $141.67. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 22, 2020 Filed Oct 26, 2020 14:46 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
Exercise / conversionCommon Stock | 95,170 | $76.18 | $7,250,050.60 |
DisclosureSEC source: 0001127602-20-027475 · form4.xml · nonDerivative · entry 1 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,555.839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 23,573 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · derivative · entry 22 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,573 shares Expires 2027-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 31,138 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · derivative · entry 21 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,138 shares Expires 2026-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 24,669 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · derivative · entry 20 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,669 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,689 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · derivative · entry 19 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 5,689 shares Expires 2017-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,514 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · derivative · entry 18 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 7,514 shares Expires 2026-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,660 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · derivative · entry 17 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 6,660 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 23,573 | $143.75 | $3,388,687.11 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 12 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,291.157 F1 · price: Weighted average price of the shares sold. The price range was $143.72 to $143.87. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionCommon Stock | 23,573 | $91.07 | $2,146,793.11 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 11 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,864.157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 31,138 | $143.75 | $4,476,177.80 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 10 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,291.157 F1 · price: Weighted average price of the shares sold. The price range was $143.72 to $143.87. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionCommon Stock | 31,138 | $80.29 | $2,500,070.02 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 9 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,429.157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 24,669 | $143.75 | $3,546,240.29 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 8 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,291.157 F1 · price: Weighted average price of the shares sold. The price range was $143.72 to $143.87. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionCommon Stock | 24,669 | $85.13 | $2,100,071.97 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 7 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,960.157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 5,689 | $144.00 | $819,216.00 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 6 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 9,988.537 Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionCommon Stock | 5,689 | $91.07 | $518,097.23 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 15,677.537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 7,514 | $144.00 | $1,082,016.00 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 4 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 9,988.537 Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionCommon Stock | 7,514 | $80.29 | $603,299.06 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 3 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 17,502.537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 6,660 | $144.00 | $959,040.00 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 9,988.537 Read SEC document |
| October 21, 2020 Filed Oct 22, 2020 19:34 UTC |
Keith R. AlexandraCEO - Beauty
|
Exercise / conversionCommon Stock | 6,660 | $85.13 | $566,965.80 |
DisclosureSEC source: 0001127602-20-027411 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 16,648.537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 18:49 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026895 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,931.091 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 18:51 UTC |
LEE DEBRA LDirector
|
GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026896 · form4.xml · nonDerivative · entry 1 LEE DEBRA L · CIK 0001119838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,387 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 18:52 UTC |
Chang AmyDirector
|
GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026897 · form4.xml · nonDerivative · entry 1 Chang Amy · CIK 0001551504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,391.581 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 18:55 UTC |
BLAKE FRANCIS SDirector
|
GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026898 · form4.xml · nonDerivative · entry 1 BLAKE FRANCIS S · CIK 0001194702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,986.617 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 19:03 UTC |
WHITMAN MARGARET CDirector
|
GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026900 · form4.xml · nonDerivative · entry 1 WHITMAN MARGARET C · CIK 0001079816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,965.392 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 18:56 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026899 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,335.0078 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:01 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026903 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,455.093 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:02 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026905 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,811.352 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:03 UTC |
MCNERNEY W JAMES JRDirector
|
GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026907 · form4.xml · nonDerivative · entry 1 MCNERNEY W JAMES JR · CIK 0001182055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,646.449 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 20:05 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 1,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026911 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,938.337 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 22:01 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
GrantCommon Stock | 1,387 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-054826 · doc4.xml · nonDerivative · entry 1 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,328 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSUs) settled in common stock. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:58 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 32,531 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026303 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,531 Underlying: Common Stock · 32,531 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:59 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 52,246 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026304 · form4.xml · derivative · entry 4 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,246 Underlying: Common Stock · 52,246 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:00 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
GrantStock Option (Right to Buy) · Derivative | 74,908 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026305 · form4.xml · derivative · entry 4 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,908 Underlying: Common Stock · 74,908 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:01 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
GrantStock Option (Right to Buy) · Derivative | 45,784 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026307 · form4.xml · derivative · entry 3 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,784 Underlying: Common Stock · 45,784 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:01 UTC |
Fish Kathleen BChf Rsch, Dev & Innv Officer
|
GrantCommon Stock | 2,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026307 · form4.xml · nonDerivative · entry 1 Fish Kathleen B · CIK 0001598156 · Chf Rsch, Dev & Innv Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,463.872 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:03 UTC |
FergusonMchugh MaryLynnCEO - Family Care & P&G Ventur
|
GrantCommon Stock | 12,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026310 · form4.xml · nonDerivative · entry 1 FergusonMchugh MaryLynn · CIK 0001613133 · CEO - Family Care & P&G Ventur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,268.8862 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:05 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantStock Option (Right to Buy) · Derivative | 33,699 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026316 · form4.xml · derivative · entry 3 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,699 Underlying: Common Stock · 33,699 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:05 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantCommon Stock | 5,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026316 · form4.xml · nonDerivative · entry 1 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,385.839 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:04 UTC |
Bishop Steven DCEO - Health Care
|
GrantStock Option (Right to Buy) · Derivative | 78,893 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026314 · form4.xml · derivative · entry 4 Bishop Steven D · CIK 0001669212 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,893 Underlying: Common Stock · 78,893 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:06 UTC |
Jejurikar ShaileshCEO - Fabric & Home Care
|
GrantStock Option (Right to Buy) · Derivative | 78,893 | $139.24 Strike: $139.24 | $10,985,061.32 |
DisclosureSEC source: 0001127602-20-026319 · form4.xml · derivative · entry 5 Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,893 Underlying: Common Stock · 78,893 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:08 UTC |
Coombe Gary ACEO - Grooming
|
GrantStock Option (Right to Buy) · Derivative | 76,086 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026322 · form4.xml · derivative · entry 4 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,086 Underlying: Common Stock · 76,086 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:09 UTC |
Taylor David SDirector · Chairman, President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 218,250 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026324 · form4.xml · derivative · entry 3 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,250 Underlying: Common Stock · 218,250 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 21:09 UTC |
Taylor David SDirector · Chairman, President & CEO
|
GrantCommon Stock | 17,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026324 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,953.5414 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 14:38 UTC |
Sheppard Valarie LController, Treas. & Group VP
|
GrantStock Option (Right to Buy) · Derivative | 17,673 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026450 · form4.xml · derivative · entry 3 Sheppard Valarie L · CIK 0001334175 · Controller, Treas. & Group VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,673 Underlying: Common Stock · 17,673 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 14:38 UTC |
Sheppard Valarie LController, Treas. & Group VP
|
GrantCommon Stock | 2,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026450 · form4.xml · nonDerivative · entry 1 Sheppard Valarie L · CIK 0001334175 · Controller, Treas. & Group VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,090.556 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 14:39 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantStock Option (Right to Buy) · Derivative | 63,873 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026451 · form4.xml · derivative · entry 7 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,873 Underlying: Common Stock · 63,873 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 15:04 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
GrantStock Option (Right to Buy) · Derivative | 14,887 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026453 · form4.xml · derivative · entry 6 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,887 Underlying: Common Stock · 14,887 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 15:04 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
GrantStock Option (Right to Buy) · Derivative | 129,890 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026453 · form4.xml · derivative · entry 5 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,890 Underlying: Common Stock · 129,890 shares Expires 2030-10-01 Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 15:04 UTC |
Moeller Jon RVice Chairman, COO and CFO
|
GrantCommon Stock | 6,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026453 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Vice Chairman, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,477.402 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.